Skip to main content
. 2017 Aug 23;7:9195. doi: 10.1038/s41598-017-09697-x

Figure 1.

Figure 1

Schematic principle and system design of photo-control over specific oncogene expression. (A) A protein (Prot) of interest genetically fused with the estrogen receptor (ERT2) is inactivated by the complex it forms with cytoplasmic chaperones (hsp). This complex can be dissociated by binding of a specific inducer (e.g. cyclofen) to ERT2. (B) A caged inducer (caged cyclofen, cInd) is chemically synthesized and can be uncaged by illumination at ~370 nm (~740 nm with a two-photon source). (C) The scheme describes how the expression of an oncogene can be photo-activated in a live cell transfected with dual fluorescent markers (EosFP and CFP). (D) This example shows that expression of the oncogene was induced selectively in one muscle fiber cell through localized uncaging of cInd in a developing zebrafish embryo. The injected embryo mosaically expressed EosFP, but only the light-activated cell expressed CFP (arrow denoted). (E,F) Two systems were used to control the transient or constitutive expression of kRASG12V. Scale bar: 200 μm.